Mayinglong Pharmaceutical Group News

Announcement of Mayinglong Pharmaceutical Group about holding the 2023 annual and 2024 first quarter performance briefing.

Jun 12 00:00

Ma Yinglong Announces Resolutions of the 14th Meeting of the 11th Board of Directors

May 29 00:00

Ma Yinglong's announcement on the renewal of the 2024 accounting firm

May 29 00:00

Ma Yinglong's Notice on Participating in the 2024 Online Investor Group Reception Day for Listed Companies in Hubei

May 11 00:00

Ma Yinglong's announcement on obtaining a drug registration certificate

Apr 17 00:00

Ma Yinglong\'s 2023 Audit Report

Apr 13 00:00

Ma Yinglong\'s special review report on the 2023 summary table of non-operating capital occupation and other related capital transactions

Apr 13 00:00

Ma Yinglong\'s 2023 Independent Director Debriefing Report (Zhang Yonghui)

Apr 13 00:00

Ma Yinglong\'s 2023 Environmental, Social and Governance (ESG) Report

Apr 13 00:00

Ma Yinglong 2023 Internal Control Audit Report

Apr 13 00:00

Ma Yinglong\'s 2023 Independent Director Debriefing Report (Mao Peng)

Apr 13 00:00

Ma Yinglong\'s 2023 Independent Director Debriefing Report (Qi Jun)

Apr 13 00:00

Ma Yinglong\'s 2023 Accounting Firm Performance Evaluation Report

Apr 13 00:00

Ma Yinglong\'s Special Opinion of the Board of Directors on the Independence of Independent Directors

Apr 13 00:00

Ma Yinglong Announces Resolutions of the 12th Meeting of the 11th Board of Directors

Apr 13 00:00

Ma Yinglong Accounting Services Selection and Employment Management Measures

Apr 13 00:00

Ma Yinglong\'s announcement on applying for a comprehensive bank credit line

Apr 13 00:00

Ma Yinglong Announces Resolutions of the Eighth Meeting of the 11th Board of Supervisors

Apr 13 00:00

Ma Yinglong's announcement on providing loan guarantee amounts for subsidiaries

Apr 13 00:00

Ma Yinglong Announces Resolutions of the 11th Meeting of the 11th Board of Directors

Dec 29, 2023 00:00